DLG4 and Alzheimer disease: However, FMT treatment could reduce the brain deposition of Aβ40 and Aβ42 and increase the expression of PSD-95 and synapsin I in AD model mice, which may be associated with increasing the abundance of Desulfovibrionaceae (Sun et al., 2019b).